Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02552186 · ClinicalTrials.gov registry record · NA
Non-invasive Clinical Pectus Index as a Measurement of Severity in Pectus
A NA study, sponsored by Johns Hopkins All Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 199
- Enrollment target
NCT02552186: Completed NA study, sponsored by Johns Hopkins All Children's Hospital.
NCT02552186 is a NA study that has completed, run by Johns Hopkins All Children's Hospital. The registered enrollment target is 199 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02552186, a NA study, has completed, sponsored by Johns Hopkins All Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
Study Summary
Pectus excavatum (PE), the most common congenital chest wall deformity, requires surgical repair when the degree of deformity is severe. Currently, the Pectus Index (PI) is used to classify PE severity. Calculation of the PI requires cross-sectional imaging of the chest, usually with computed tomography (CT) or Magnetic Resonance Imaging (MRI), to obtain the necessary measurements. However, CT delivers a high dose of ionizing radiation, which carries cumulative long-term risks of malignancy and MRI can be costly. The purpose of this study is to develop a method whereby accurate chest wall measurements can be obtained to quantify PE severity without the need for cross-sectional imaging.
Primary Outcome
Sensitivity refers to the ability of the test to correctly identify those patients with the disease.
Interventions
- OTHER Caliper measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-12 |
| Phase | NA |
What the finished NCT02552186 record still lists
NCT02552186 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Caliper measurement is the first listed.
NCT02552186 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02552186 about?
NCT02552186 is a clinical study titled "Non-invasive Clinical Pectus Index as a Measurement of Severity in Pectus". Pectus excavatum (PE), the most common congenital chest wall deformity, requires surgical repair when the degree of deformity is severe. Currently, the Pectus Index (PI) is used to classify PE severity. Calculation of the PI requires cross-sectional imaging of the chest, usually with computed tomogr...
What is the current status of trial NCT02552186?
This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2015-09. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02552186?
The interventions under investigation include: Caliper measurement (OTHER).
Who is sponsoring clinical trial NCT02552186?
This trial is sponsored by Johns Hopkins All Children's Hospital, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02552186's enrollment target sits among peer trials
199 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia